Positioning Providers to Take on Risk
As the market moves rapidly toward value-based care, one physician describes how working with New Century Health gave his practice the confidence and support to succeed in an advanced alternative payment model.
Other content in this Stream
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols
Join us on June 9 for a webinar to explore the future of cancer care in a post COVID-19 world.
Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.
Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.
Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.
A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.
Creating a "Culture of Yes" in Prior Authorization
Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.
The Financial Burden of Breast Cancer
As more cancers are treated like chronic conditions, financial toxicity has become a greater problem, our CMO Dr. Andrew Hertler tells Next Avenue.
Navigating the CMS Oncology Care Model can be complicated. Listen to oncologist Dr. Wade describe his OCM experiences and how a partnership with New Century Health positioned his practice for success.
Lower Patient Costs Doesn’t Have to Mean Lower Profits
As the pace of treatment innovation threatens the financial health of both patients and oncology practices, it’s time to redefine reimbursement models to care for both financial and physical outcomes.
New Century Health’s clinical pathways are rigorously developed and maintained by company clinicians under the oversight of an independent Scientific Advisory Board. Take a glimpse inside the board.
Four Ways to Adapt to New Oncology Value-Based Models
Our CMO Dr. Andrew Hertler is quoted extensively in this Managed Healthcare Executive roundup of strategies for driving value in cancer care.
Oncology drug spending in the U.S. is on an unsustainable trajectory. Explore four paths to curb costs without compromising care.
Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus
Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.
Oncology Care First: What Providers Need to Know About CMS’ Proposed Model for Value-Based Cancer Care
Learn how CMS aims to increase risk, cash flow and predictability for practices while reducing administrative burdens, through its next model for value-based oncology care.
Cancer Spending in Medicaid: From Unmanaged Problem to Untapped Opportunity
As cancer drug prices soar and innovation continues at a dizzying pace, Medicaid plans need a new set of tools to rein in spending and ensure high quality care.
Five Ways Oncology Has Become More Personalized
How do you deliver individualized cancer care from both a scientific and human perspective? Read Managed Care Executive for our CMO Dr. Andrew Hertler's thoughts.
Putting the CAR-T Before the Horse? Understanding CMS’ Recent Cancer Therapy Decisions
Dr. Hertler, CMO at New Century Health, shares his thoughts and perspectives on the future of CAR T-cell therapy and the recent CMS announcements.
Cancer Care Costs Everyone Too Much. Here's How We Fix It.
Dr. Andrew Hertler, Chief Medical Officer at New Century Health, demonstrates how clinical pathways improve patient outcomes while decreasing waste and cost.